Once a treatment starts scaling up for clinical use, any gap in vector production could bring costly delays, both for developers expecting a return on their investment, and for patients waiting to ...

Healthcare-associated infections (HAIs) pose a persistent and tremendous threat to patient safety, having claimed 72,000 patients during their hospitalization according to the Centers for Disease ...